Targeting STAT3 signaling to promote recovery from neuropathic pain
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210681
- Recipient
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $580,444
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Houston, TX 77030, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $580,444 Project Grant to The University of Texas M.D. Anderson Cancer Center through the Military Medical Research and Development program. The grant will fund research from August 15, 2022 to August 14, 2025 to target STAT3 signaling pathways to promote recovery from neuropathic pain.
The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of improving military and public health outcomes. This award will allow the Cancer Center to investigate medical solutions for neuropathic pain experienced by service members, with the ultimate aim of transforming pain treatment for both military and civilian populations. The University of Texas System serves as the Cancer Center's parent organization overseeing the research efforts.
Quick answers
Who received award W81XWH2210681?
W81XWH2210681 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Medical Command (Department of the Army) on August 15, 2022.
How much is award W81XWH2210681 worth?
$580,444 has been obligated on W81XWH2210681.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award